BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27833165)

  • 1. Genetic and pharmacological inhibition of CDK9 drives neutrophil apoptosis to resolve inflammation in zebrafish in vivo.
    Hoodless LJ; Lucas CD; Duffin R; Denvir MA; Haslett C; Tucker CS; Rossi AG
    Sci Rep; 2016 Nov; 5():36980. PubMed ID: 27833165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Cdk9 inhibition resolves neutrophilic inflammation and enhances cardiac regeneration in larval zebrafish.
    Kaveh A; Bruton FA; Oremek MEM; Tucker CS; Taylor JM; Mullins JJ; Rossi AG; Denvir MA
    Development; 2022 Apr; 149(8):. PubMed ID: 34523672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-dependent kinase 9 activity regulates neutrophil spontaneous apoptosis.
    Wang K; Hampson P; Hazeldine J; Krystof V; Strnad M; Pechan P; M J
    PLoS One; 2012; 7(1):e30128. PubMed ID: 22276149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK9 and its repressor LARP7 modulate cardiomyocyte proliferation and response to injury in the zebrafish heart.
    Matrone G; Wilson KS; Maqsood S; Mullins JJ; Tucker CS; Denvir MA
    J Cell Sci; 2015 Dec; 128(24):4560-71. PubMed ID: 26542022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Cyclin Dependent Kinase 9 inhibition on zebrafish larvae.
    Matrone G; Mullins JJ; Tucker CS; Denvir MA
    Cell Cycle; 2016 Nov; 15(22):3060-3069. PubMed ID: 27715402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation.
    Leitch AE; Lucas CD; Marwick JA; Duffin R; Haslett C; Rossi AG
    Cell Death Differ; 2012 Dec; 19(12):1950-61. PubMed ID: 22743999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Mcl-1 has anti-inflammatory pro-resolution effects and enhances bacterial clearance from the lung.
    Lucas CD; Dorward DA; Tait MA; Fox S; Marwick JA; Allen KC; Robb CT; Hirani N; Haslett C; Duffin R; Rossi AG
    Mucosal Immunol; 2014 Jul; 7(4):857-68. PubMed ID: 24280938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CXCL12/CXCR4 Signaling Axis Retains Neutrophils at Inflammatory Sites in Zebrafish.
    Isles HM; Herman KD; Robertson AL; Loynes CA; Prince LR; Elks PM; Renshaw SA
    Front Immunol; 2019; 10():1784. PubMed ID: 31417560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cyclin-dependent kinase 9 is a potential biomarker of atherosclerotic inflammation.
    Han Y; Zhao S; Gong Y; Hou G; Li X; Li L
    Oncotarget; 2016 Jan; 7(2):1854-62. PubMed ID: 26636538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK9 inhibition strategy defines distinct sets of target genes.
    Garriga J; Graña X
    BMC Res Notes; 2014 May; 7():301. PubMed ID: 24886624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavopiridol protects against inflammation by attenuating leukocyte-endothelial interaction via inhibition of cyclin-dependent kinase 9.
    Schmerwitz UK; Sass G; Khandoga AG; Joore J; Mayer BA; Berberich N; Totzke F; Krombach F; Tiegs G; Zahler S; Vollmar AM; Fürst R
    Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):280-8. PubMed ID: 21088252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of hypoxia-inducible factor-1α (Hif-1α) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model.
    Elks PM; van Eeden FJ; Dixon G; Wang X; Reyes-Aldasoro CC; Ingham PW; Whyte MK; Walmsley SR; Renshaw SA
    Blood; 2011 Jul; 118(3):712-22. PubMed ID: 21555741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EGFR/ErbB inhibitor neratinib modifies the neutrophil phosphoproteome and promotes apoptosis and clearance by airway macrophages.
    Herman KD; Wright CG; Marriott HM; McCaughran SC; Bowden KA; Collins MO; Renshaw SA; Prince LR
    Front Immunol; 2022; 13():956991. PubMed ID: 35967296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation.
    Gordon V; Bhadel S; Wunderlich W; Zhang J; Ficarro SB; Mollah SA; Shabanowitz J; Hunt DF; Xenarios I; Hahn WC; Conaway M; Carey MF; Gioeli D
    Mol Endocrinol; 2010 Dec; 24(12):2267-80. PubMed ID: 20980437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cyclin-dependent kinase inhibitor R-roscovitine down-regulates Mcl-1 to override pro-inflammatory signalling and drive neutrophil apoptosis.
    Leitch AE; Riley NA; Sheldrake TA; Festa M; Fox S; Duffin R; Haslett C; Rossi AG
    Eur J Immunol; 2010 Apr; 40(4):1127-38. PubMed ID: 20127676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
    Dow EC; Liu H; Rice AP
    J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pivotal Advance: Pharmacological manipulation of inflammation resolution during spontaneously resolving tissue neutrophilia in the zebrafish.
    Loynes CA; Martin JS; Robertson A; Trushell DM; Ingham PW; Whyte MK; Renshaw SA
    J Leukoc Biol; 2010 Feb; 87(2):203-12. PubMed ID: 19850882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of CDK9 prevents mechanical injury-induced inflammation, apoptosis and matrix degradation in cartilage explants.
    Hu Z; Yik JH; Cissell DD; Michelier PV; Athanasiou KA; Haudenschild DR
    Eur Cell Mater; 2016; 30():200-9. PubMed ID: 26859911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemia.
    Yeh YY; Chen R; Hessler J; Mahoney E; Lehman AM; Heerema NA; Grever MR; Plunkett W; Byrd JC; Johnson AJ
    Oncotarget; 2015 Feb; 6(5):2667-79. PubMed ID: 25596730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9.
    Itkonen HM; Poulose N; Steele RE; Martin SES; Levine ZG; Duveau DY; Carelli R; Singh R; Urbanucci A; Loda M; Thomas CJ; Mills IG; Walker S
    Mol Cancer Res; 2020 Oct; 18(10):1512-1521. PubMed ID: 32611550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.